More science highlights from ASTRO on UroToday! #ASTRO22 #ASTRO2022 #AI #ArteraAI urotoday.com/conference-hig… via UroToday.com

Thrilled to see a great turnout for the amazing IBC update from the incomparable Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 Dana-Farber IBC Program highlighting progress in biology, partnership with Susan G. Komen MD Anderson Cancer Center for diagnosis tools and efforts to move good M1 tx to the M0 IBC setting! #SABCS2022

#ArteraAI is at #GU23! Don't miss today's presentation with Daniel E Spratt, as he shares results from six phase III randomized trials and how the use of MMAI prognostic biomarkers may improve the ability to assess risk in patients with #prostatecancer.⚕️ #ASCOGU

🏎️ FORMULA 509 Paul Nguyen #GU23 #pcsm OncoAlert Salvage RT (med dose 68.4 Gy, 26% nodes tx) w 6 mos ADT ±intensification w AAP/Apa Overall PFS HR 0.71 p=.06 However pre-specified subgrp PSA>0.5 PFS HR 0.5, P=.03; MFS HR 0.32 p=.02 👉 potential alt to longer ADT in this pop

The Artera team is heading to #BiomarkersSeries23 2/27-2/28 in Manchester. 🇬🇧 Don't miss Dr. Tim Showalter's presentation "Pathology-Based Deep Learning Tools to Personalize Treatment Decisions: #ArteraAI #ProstateTest Development & Validation" on 2/27! bit.ly/3XEatCb

What if there was a way to identify the patients who would benefit from therapy intensification? With #ArteraAI, there is. 💙 ➡️ Learn more about The ArteraAI #ProstateTest: artera.ai/our-test

Did you catch Tim Showalter's presentation at #BiomarkersSeries23? 🇬🇧 Members of the Artera team met with attendees to discuss how the #ArteraAI #ProstateTest can help identify patients who will benefit from therapy intensification. ➡️ Learn more: artera.ai/our-test/

Congrats to Kara and the UVA team on completing the trial! Very excited to see the great results

Shark tank at ABS#2023 presentation on Chat GPT for brachy education ⁦Tim Showalter⁩ ⁦Pranshu Mohindra⁩

So much fun getting to be a shark for this! Exciting to see the potential impact of AI in brachytherapy. Congratulations to all three of the presenters for compelling proposals and pitches.

Are you passionate about #artificialintelligence and innovation in medical care? Join our team! Are you looking to make a difference with your career? #ArteraAI is seeking a #ClinicalResearch Associate. ➡️ Get full job details and apply here today: bit.ly/3PhrDVr

Amazing work with direct clinical impact! Congrats to Daniel E Spratt NRG Oncology and the team at ArteraAI

Can we take lessons learned from #prostatecancer into #kidneycancer? Tim Showalter says yes! KidneyCAN @kidneycancer KCCure #KCRS23

Thank you for the invitation to share the potential impact we can make together for patients with #RCC #KCRS23 ArteraAI

Dr. Tim Showalter from ArteraAI presented the data from prostate cancer and discussed possibilities of integrating tissue AI analysis in RCC. Very promising to have AI integration in RCC. #KCRS23 OncoAlert

Congratulations to our friends and colleagues ArteraAI —their multimodal #ArtificialInteligence platform is revolutionary and applicable clinically. Bravo ArteraAI team! TIME time.com/7094698/artera…

We’re proud to have Marc Benioff on Artera’s board, helping shape how AI transforms precision medicine. Check out his latest interview on the future of AI in business via Chief Executive: heyor.ca/mpLN8u #AIinHealthcare #MarcBenioff #Leadership

In this episode we chat w ⁦Othman Laraki CEO/cofounder⁩ ⁦Color⁩ - give us a listen for a story of impact and inspiration for how health technology can improve care delivery podcasts.apple.com/us/podcast/hea…